Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)

RECOMMENDED

EmphysemaInterstitial Lung DiseasePulmonary Fibrosis

Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS® study)

Eur Respir J.

Nasser M, Larrieu S, Si-Mohamed S, Ahmad K, Boussel L, Brevet M, Chalabreysse L, Fabre C, Marque S, Revel D, Thivolet-Bejui F, Traclet J, Zeghmar S, Maucort-Boulch D, Cottin V

doi: 10.1183/13993003.02718-2020.

RECOMMENDED

Interstitial Lung Disease

The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation

★ 2 Recommended by Dr Martin Frey, Faculty Member

J Clin Med.

Atienza-Mateo B, Remuzgo-Martínez S, Mora Cuesta VM, Iturbe-Fernández D, Fernández-Rozas S, Prieto-Peña D, Calderón-Goercke M, Corrales A, Blanco Rodríguez GB, Gómez-Román JJ, González-Gay MÁ, Cifrián JM

doi: 10.3390/jcm9061606.

Interstitial Lung Disease

Telomere Length and Genetic Variant Associations with Interstitial Lung Disease Progression and Survival

Eur Respir J.

Newton CA, Oldham JM, Ley B, Anand V, Adegunsoye A, Liu G, Batra K, Torrealba J, Kozlitina J, Glazer C, Strek ME5, Wolters PJ, Noth I, Garcia CK

doi: 10.1183/13993003.

RECOMMENDED

EmphysemaInterstitial Lung DiseasePulmonary Fibrosis

Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS® study)

★ 3 Recommended by Dr Martin Frey, Faculty Member

Eur Respir J

Nasser M, Larrieu S, Si-Mohamed S, Ahmad K, Boussel L, Brevet M, Chalabreysse L, Fabre C, Marque S, Revel D, Thivolet-Bejui F, Traclet J, Zeghmar S, Maucort-Boulch D, Cottin V

doi: 10.1183/13993003.02718-2020

RECOMMENDED

Interstitial Lung DiseasePulmonary Fibrosis

The natural history of progressive fibrosing interstitial lung diseases

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

★ 2 Recommended by Dr Martin Frey, Faculty Member

doi: 10.1183/13993003.00085-2020.

RECOMMENDED

Interstitial Lung DiseasePulmonary Fibrosis

Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

★ 3 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended by Dr Marcus Hesse, Faculty Member

Lancet Respir Med.

Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, Moua T, Crestani B, Wuyts WA, Stowasser S, Quaresma M, Goeldner RG, Schlenker-Herceg R, Kolb M, INBUILD trial investigators.

doi: 10.1016/S2213-2600(20)30036-9.

RECOMMENDED

Interstitial Lung DiseasePneumonia

Predictors of Progression and Mortality in Patients with Prevalent Rheumatoid Arthritis and Interstitial Lung Disease: A Prospective Cohort Study

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended by Dr Marcus Hesse, Faculty Member

J Clin Med

Mena-Vázquez N, Rojas-Gimenez M, Romero-Barco CM, Manrique-Arija S, Francisco E, Aguilar-Hurtado MC, Añón-Oñate I, Pérez-Albaladejo L, Ortega-Castro R, Godoy-Navarrete FJ, Ureña-Garnica I, Velloso-Feijoo ML, Redondo-Rodriguez R, Jimenez-Núñez FG, Panero Lamothe B, Padin-Martín MI, Fernández-Nebro A

doi: 10.3390/jcm10040874

RECOMMENDED

Interstitial Lung Disease

The psychometric properties of the King's Brief Interstitial Lung Disease questionnaire and thresholds for meaningful treatment response in patients with progressive fibrosing interstitial lung diseases

★ 1 Recommended by Dr Martin Frey, Faculty Member

Eur Respir J

Birring SS, Bushnell DM, Baldwin M, Mueller H, Male N, Rohr KB, Inoue Y

doi: 10.1183/13993003.01790-2021

Interstitial Lung Disease

The ILD-GAP Risk Prediction Model Performs Poorly in Myositis-Associated Interstitial Lung Disease

Respir Med.

Brusca RM, Pinal-Fernandez I, Psoter K, Paik JJ, Albayda J, Mecoli C, Tiniakou E, Mammen AL, Cristopher-Stine L, Danoff SD, Johnson C

doi: 10.1016/j.rmed.

Related content

Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS® study)

The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation

Telomere Length and Genetic Variant Associations with Interstitial Lung Disease Progression and Survival

Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS® study)

The natural history of progressive fibrosing interstitial lung diseases

Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Predictors of Progression and Mortality in Patients with Prevalent Rheumatoid Arthritis and Interstitial Lung Disease: A Prospective Cohort Study

The psychometric properties of the King's Brief Interstitial Lung Disease questionnaire and thresholds for meaningful treatment response in patients with progressive fibrosing interstitial lung diseases

The ILD-GAP Risk Prediction Model Performs Poorly in Myositis-Associated Interstitial Lung Disease